EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hereditary breast cancer next‐generation sequencing panel evaluation in the south region of Brazil: A novel BRCA2 candidate pathogenic variant is reported

Cesar Augusto B Duarte iD, Carlos Alberto Dos Santos, Cristine Domingues D de Oliveira, Cleverton César Spautz, Laura Masami Sumita, Sueli Massumi Nakatani

Molecular Genetics & Genomic Medicine · 2024

DOI: 10.1002/mgg3.2504 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, 2024. Verfasst von Cesar Augusto B Duarte und 5 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development Division, Genoprimer Diagnóstico Molecular, Curitiba, Paraná, Brazil. Hauptthemen laut MEDLINE: BRCA2 Protein, Breast Neoplasms, Checkpoint Kinase 2, High-Throughput Nucleotide Sequencing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: None..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In this article, we delineate a loosely selected cohort comprising patients with a history of early‐onset breast cancer and/or a familial occurrence of cancer. The aim of this study was to gain insights into the presence of breast cancer‐related gene variants in a population from a micro‐region in southern Brazil, specifically the Metropolitan Region of Curitiba. This area exhibits a highly genetically mixed population, mirroring the general characteristics of the Brazilian people.

Methods

Comprehensive next‐generation sequencing (NGS) multigene panel testing was conducted on 12 patients from the region, utilizing three different library preparation methods.

Results

Two pathogenic variants and one candidate pathogenic variant were identified: BRCA2 c.8878C>T, p.Gln2960Ter; CHEK2 c.1100del, p.Thr367Metfs15, and BRCA2 c.3482dup, p.Asp1161Glufs3.

Conclusion

BRCA2 c.3482dup, a novel candidate pathogenic variant, previously unpublished, is reported. The prevalence of pathogenic variants in this small cohort is similar to that described in the literature. All different library preparation methods were equally proficient in enabling the detection of these variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BRCA2 ProteinBreast NeoplasmsCheckpoint Kinase 2High-Throughput Nucleotide SequencingHumansFemaleBrazilMiddle AgedAdultGenetic TestingGenetic Predisposition to Disease

Stichwörter der Autor:innen

BRCA2 mutationhereditary breast cancernext‐generation sequencingvariant interpretation

Substanzen

BRCA2 ProteinBRCA2 protein, humanCheckpoint Kinase 2CHEK2 protein, human

Autor:innen und Institutionen

  • Research and Development Division, Genoprimer Diagnóstico Molecular, Curitiba, Paraná, Brazil.
  • Molecular Biology Clinical Laboratory, Clinimol Diagnóstico Molecular, São Paulo, São Paulo, Brazil.
  • Department of Surgery, Hospital Nossa Senhora das Graças, Curitiba, Paraná, Brazil.

ORCID-Profile: Cesar Augusto B Duarte

Förderung

  • None.

Zitieren

APA

Duarte, C. A. B., Dos Santos, C. A., de Oliveira, C. D. D., Spautz, C. C., Sumita, L. M., & Nakatani, S. M. (2024). Hereditary breast cancer next‐generation sequencing panel evaluation in the south region of Brazil: A novel BRCA2 candidate pathogenic variant is reported. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.2504

Vancouver

Duarte CAB, Dos Santos CA, de Oliveira CDD, Spautz CC, Sumita LM, Nakatani SM. Hereditary breast cancer next‐generation sequencing panel evaluation in the south region of Brazil: A novel BRCA2 candidate pathogenic variant is reported. Molecular Genetics & Genomic Medicine. 2024. doi:10.1002/mgg3.2504

BibTeX
@article{Duarte2024,
  author = {Duarte, Cesar Augusto B and Dos Santos, Carlos Alberto and de Oliveira, Cristine Domingues D and Spautz, Cleverton César and Sumita, Laura Masami and Nakatani, Sueli Massumi},
  title = {Hereditary breast cancer next‐generation sequencing panel evaluation in the south region of Brazil: A novel BRCA2 candidate pathogenic variant is reported},
  journal = {Molecular Genetics & Genomic Medicine},
  year = {2024},
  doi = {10.1002/mgg3.2504}
}
Kostenlos starten →